Director Lemonis Reports Another Large OSTK Buy

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction is another Form 4 filing by Marcus Lemonis, director of $OSTK.

Lemonis reported an OSTK purchase worth $595,933.

OSTK also saw bullish flow in the options market.

Paradigm BioCapital Advisors LP filed a 13G for Nuvalent Inc $NUVL revealing an initial stake of 5.90%.

Here’s The Hot Corner, with data through October 30, 2023:

In another Form 4, the Chief R&D officer of Keurig Dr Pepper Inc $KDP revealed a purchase of $211,147.

In addition to OSTK, there was also bullish options flow in Payoneer Global Inc $PAYO.

Stay tuned. We’ll be back on Wednesday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Source link

Be the first to comment

Leave a Reply

Your email address will not be published.